Medicinal application of astragalus polysaccharide in prevention and treatment of leptospirosis

A technology for leptospirosis and astragalus polysaccharide is applied in the field of medicine to achieve the effects of reducing the use of antibiotics, developing huge health and expanding the scope of medicinal use

Inactive Publication Date: 2020-02-28
JILIN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are few reports on the prevention and treatment of Leptospira

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal application of astragalus polysaccharide in prevention and treatment of leptospirosis
  • Medicinal application of astragalus polysaccharide in prevention and treatment of leptospirosis
  • Medicinal application of astragalus polysaccharide in prevention and treatment of leptospirosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Astragalus polysaccharides are used as drugs to prevent and treat leptospirosis.

Embodiment 2

[0020] Astragalus polysaccharides as drugs for preventing and treating leptospirosis are suitable for any pharmaceutically acceptable carrier.

Embodiment 3

[0022] The pharmaceutical preparation used is a standard liquid preparation of astragalus polysaccharide, and the astragalus polysaccharide powder is dissolved and diluted with normal saline according to the dosage.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides medicinal application of astragalus polysaccharide in prevention and treatment of leptospirosis. In the medicinal application, a standard product of the astragalus polysaccharide is injected to golden hamsters sensitive to leptospiras in advance at a dose of 50mg/kg, infections of the leptospiras can be effectively controlled after the golden hamsters are infected with 2*10<8> ml of the leptospiras, and the survival rate reaches 100%. The medicinal application range of the astragalus polysaccharide is widened, and a basis is provided for development of new application ofthe astragalus polysaccharide.

Description

Technical field [0001] The present invention provides a new medical use of astragalus polysaccharides, in particular discloses a use of astragalus polysaccharides in the preparation of prevention and treatment of leptospirosis, belonging to the technical field of medicine. Background technique [0002] Leptospirosis is a zoonotic disease that spreads worldwide, referred to as Leptospirosis. This infection is related to occupational or life contact and contact with Leptospira. It is highly prevalent in flood-prone areas. The disease is especially widespread in developing countries and tropical regions. Humans and animals are susceptible to the disease, and the clinical manifestations after infection are diverse and difficult to diagnose. The pathogen of leptospirosis will continue to exist in the host body, and will further spread to pollute the environment, infect other people and animals, and cause serious harm. At present, the methods of preventing and treating Leptospira are...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/715A61P31/04
CPCA61K31/715A61P31/04Y02A50/30
Inventor 曹永国宋宁张文龙谢旭峰吕天宝张石磊丁越王佳琪吴殿君
Owner JILIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products